Description
CJC-1295 (without DAC) is a synthetic peptide that acts as a growth-hormone–releasing hormone (GHRH) analogue.
It’s designed to bind to the same receptors as your body’s natural GHRH and trigger the pituitary to release growth hormone (GH) and, secondarily, IGF-1.
Research status & potential uses
-
Studied experimentally for:
-
GH deficiency and metabolic issues
-
Body composition and recovery (animal / early human data only)
-
-
No major regulator (FDA, EMA, etc.) has approved it for any therapy.

